“All medicines have side effects, but it’s just about trying to minimize the impact through providing the information patients and clinicians need or finding other
Category: Science
Strategic Focus: Alexis Cocozaki on the pathway to early discovery at Ipsen
“To succeed at this, you need to have some tolerance for failure and risk taking.” At the heart of Ipsen’s
A Life in Science: The role of data in advancing medicines
New in our A Life in Science series, we hear from Audrey Clapéron, Translational Biology Director, about the essential role of data in
From culture to clinic: Alison Mason on making science work at scale
“We’re doing real science. For real people. And we’re doing it together. That’s what matters most to me.” – Alison Mason The science
A Life in Science: Shaping early development with patient focus
New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development,
A Life in Science: Curiosity and collaboration in cancer research
New in our A Life in Science series, we hear from Elodie Lewkowicz, Asset Lead, about how curiosity and collaboration
From idea to impact: accelerating the promise of early science
By Christelle Huguet, EVP & Head of R&D, Ipsen Every year, new breakthroughs reveal possibilities for treating conditions once thought
A model for modern biopharma collaboration — the enduring partnership between Ipsen and IRICoR
In an era where breakthrough science increasingly depends on deep, cross sector collaboration, the longstanding partnership between Ipsen and the
A Life in Science: Adapting science through diverse perspectives
New in our A Life in Science series, we hear from Florence Meyer-Losic, Vice President and Head of Translational Sciences, about her
A Life in Science: Teamwork and resilience in early development
New in our A Life in Science series, we hear from Eli Leo, Early Development Asset Lead, about how teamwork, creativity, and